Evidence check: Vitamin D 25-OH in the context of Wechseljahre

Measuring 25-OH vitamin D during menopause is clinically relevant because declining estrogen accelerates bone turnover, and deficiency increases osteoporosis risk. However, the provided context lacks direct studies or guidelines on this specific combination. The evidence for routine testing in all menopausal women is moderate: treating confirmed deficiency is beneficial, but universal screening without risk factors is not strongly supported. The test reflects current status, not genetic predisposition. Caveat: clinical decisions should consider individual risk factors (e.g., bone density, sun exposure). The result is time-sensitive due to seasonal variation. No direct sources from the given context.